British Cardiovascular Intervention Soc - Charities report - 22.2

British Cardiovascular Intervention Soc - Charities report - 22.2


IRIS Accounts Production v24.1.4.33 Other Company accounts True false Pounds 1.10.22 30.9.23 30.9.23 FY FRS 102 Independent examiner Small companies regime for accounts Full Charities SORP true true true true true false true false true false 0 0 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh073260462022-09-30073260462023-09-30073260462022-10-012023-09-30073260462021-09-30073260462021-10-012022-09-30073260462022-09-3007326046ns0:CharitableCompanyLimitedByGuarantee2022-10-012023-09-3007326046ns15:PoundSterling2022-10-012023-09-3007326046ns11:FRS1022022-10-012023-09-3007326046ns11:IndependentExaminationCharity2022-10-012023-09-3007326046ns11:SmallCompaniesRegimeForAccounts2022-10-012023-09-3007326046ns11:FullAccounts2022-10-012023-09-3007326046ns11:CharitiesSORP2022-10-012023-09-300732604622022-10-012023-09-3007326046ns16:EnglandWales2022-10-012023-09-3007326046ns11:RegisteredOffice2022-10-012023-09-3007326046ns0:Trustee22022-10-012023-09-3007326046ns0:Trustee32022-10-012023-09-3007326046ns0:Trustee42022-10-012023-09-3007326046ns0:Trustee12022-10-012023-09-3007326046ns0:Trustee52022-10-012023-09-3007326046ns0:Trustee62022-10-012023-09-3007326046ns0:Activity82022-10-012023-09-3007326046ns0:Activity82021-10-012022-09-3007326046ns0:Activity92022-10-012023-09-3007326046ns0:Activity92021-10-012022-09-3007326046ns10:WithinOneYear2023-09-3007326046ns10:WithinOneYear2022-09-3007326046ns0:TotalUnrestrictedFunds2023-09-300732604622022-10-012023-09-300732604632022-10-012023-09-3007326046ns10:ComputerSoftware2022-10-012023-09-3007326046ns10:ComputerSoftware2021-10-012022-09-3007326046ns10:ComputerSoftware2022-09-3007326046ns10:ComputerSoftware2023-09-3007326046ns10:ComputerSoftware2022-09-30
REGISTERED COMPANY NUMBER: 07326046 (England and Wales)
REGISTERED CHARITY NUMBER: 1138385



















REPORT OF THE TRUSTEES AND

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 SEPTEMBER 2023

FOR

BRITISH CARDIOVASCULAR INTERVENTION
SOCIETY

BRITISH CARDIOVASCULAR INTERVENTION
SOCIETY

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2023










Page

Report of the Trustees 1 to 2

Independent Examiner's Report 3

Statement of Financial Activities 4

Balance Sheet 5 to 6

Notes to the Financial Statements 7 to 12

BRITISH CARDIOVASCULAR INTERVENTION
SOCIETY (REGISTERED NUMBER: 07326046)

REPORT OF THE TRUSTEES
FOR THE YEAR ENDED 30 SEPTEMBER 2023



The trustees present their report with the financial statements of the charity for the year ended 30 September 2023. The trustees have adopted the provisions of Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102) (effective 1 January 2019).

OBJECTIVES AND ACTIVITIES
Objectives and aims
The objects of the Society are:-

To promote for the public benefit the education of those involved in the field of coronary angloplasty, cardiac valvuloplasty and other interventional cardiovascular procedures ("the Field") and

To protect, promote and maintain the health and safety of the community by carrying out medical research in the Field and helping to maintain and raise standards of care in the Field.

In setting the objectives of the company and planning its activities the trustees have given careful consideration to the Charity Commission's general guidance on public benefit.

ACHIEVEMENT AND PERFORMANCE
Charitable activities
BCIS continues to pursue its objectives in education, training, research and supporting the development of the care of patients with cardiovascular disease. The society's long standing national meeting - Advanced Cardiovascular Intervention - goes from strength to strength and attracted more delegates then ever. Additional educational meetings through the year attend to the educational needs of trainees and allied health professionals.The remit of the advanced meeting has been expanded beyond coronary intervention and we now provide education on a wide range of other issues such as structural heart disease intervention and service organisation.

FINANCIAL REVIEW
Financial position
The funding of the charity's activities during the year has been conducted wholly from income received during the current and previous years, unrestricted funds have decreased by £2,868 during the year.

Investment policy and objectives
The trustees' policy is to invest funds in easy access and low risk bank accounts.

Reserves policy
At the year end the Society has unrestricted reserves of £306,586 (2022: £361,958).

The trustees consider this level of resources sufficient to cover immediate expenditure requirements.

STRUCTURE, GOVERNANCE AND MANAGEMENT
Governing document
The British Cardiovascular Intervention Society was incorporated on 26 July 2010 as a company limited by guarantee and registered with the Charity Commission on 12 October 2010.

The Society is governed by its Memorandum and Articles of Association.

Recruitment and appointment of new trustees
Trustees are appointed by ordinary members as per the Articles of Association.

The council may appoint a trustee to fill a vacancy or as an additional trustee. A trustee so appointed holds office only until the next annual general meeting.

Organisational structure
The charity is administered and managed by a council, who are directors of the charity, in accordance with the governing document.

BRITISH CARDIOVASCULAR INTERVENTION
SOCIETY (REGISTERED NUMBER: 07326046)

REPORT OF THE TRUSTEES
FOR THE YEAR ENDED 30 SEPTEMBER 2023


STRUCTURE, GOVERNANCE AND MANAGEMENT
Induction and training of new trustees
No formal trustee induction and training procedures have been adopted.

Risk management
The trustees confirm that the major risks to which the charity is exposed, as identified by the trustees, have been reviewed and systems established to mitigate the risk.

REFERENCE AND ADMINISTRATIVE DETAILS
Registered Company number
07326046 (England and Wales)

Registered Charity number
1138385

Registered office
Unit 8
Midland Court
Lutterworth
LEICESTER
LE17 4PN

Trustees
Professor N P Curzen Cardiologist (resigned 31/3/2023)
Dr C E Appleby Cardiologist (resigned 31/3/2023)
Dr D G W Fraser Doctor (resigned 31/3/2023)
Dr D B McKenzie Consultant Cardiologist
Dr D Hildick-Smith Cardiologist (appointed 24/3/2023)
Dr G J Clesham Cardiologist (appointed 31/3/2023)

Professor P MacCarthy
Dr P Ludman (Audit Secretary)
Dr D Muir
Professor R Kharbanda
Dr G Clesham
Professor C Berry
Dr S Nijjer

Independent Examiner
Johnson Tidsall Limited
Chartered Accountants
81 Burton Road
Derby
Derbyshire
DE1 1TJ

Approved by order of the board of trustees on 5 June 2024 and signed on its behalf by:





Dr D B McKenzie - Trustee

INDEPENDENT EXAMINER'S REPORT TO THE TRUSTEES OF
BRITISH CARDIOVASCULAR INTERVENTION
SOCIETY


Independent examiner's report to the trustees of British Cardiovascular Intervention Society ('the Company')
I report to the charity trustees on my examination of the accounts of the Company for the year ended 30 September 2023.

Responsibilities and basis of report
As the charity's trustees of the Company (and also its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ('the 2006 Act').

Having satisfied myself that the accounts of the Company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity's accounts as carried out under Section 145 of the Charities Act 2011 ('the 2011 Act'). In carrying out my examination I have followed the Directions given by the Charity Commission under Section 145(5) (b) of the 2011 Act.

Independent examiner's statement
Since your charity's gross income exceeded £250,000 your examiner must be a member of a listed body. I can confirm that I am qualified to undertake the examination because I am a member of the Institute of Chartered Accountants in England and Wales, which is one of the listed bodies.

I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe:

1. accounting records were not kept in respect of the Company as required by Section 386 of the 2006 Act; or
2. the accounts do not accord with those records; or
3. the accounts do not comply with the accounting requirements of Section 396 of the 2006 Act other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination; or
4. the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities (applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)).

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.








Richard Minns FCA

Johnson Tidsall Limited
Chartered Accountants
81 Burton Road
Derby
Derbyshire
DE1 1TJ

Date: .............................................

BRITISH CARDIOVASCULAR INTERVENTION
SOCIETY

STATEMENT OF FINANCIAL ACTIVITIES
FOR THE YEAR ENDED 30 SEPTEMBER 2023

2023 2022
Unrestricted Total
fund funds
Notes £    £   
INCOME AND ENDOWMENTS FROM
Charitable activities
Cardiovascular care 329,755 240,354

Investment income 3 1,723 35
Total 331,478 240,389

EXPENDITURE ON
Charitable activities
Cardiovascular care 384,780 -
Cardiovascular care - 241,187

Other 2,070 2,070
Total 386,850 243,257

NET INCOME/(EXPENDITURE) (55,372 ) (2,868 )


RECONCILIATION OF FUNDS
Total funds brought forward 361,958 364,826

TOTAL FUNDS CARRIED FORWARD 306,586 361,958

BRITISH CARDIOVASCULAR INTERVENTION
SOCIETY (REGISTERED NUMBER: 07326046)

BALANCE SHEET
30 SEPTEMBER 2023

2023 2022
Unrestricted Total
fund funds
Notes £    £   
FIXED ASSETS
Intangible assets 7 15,525 17,595

CURRENT ASSETS
Debtors 8 15,144 144
Cash at bank 295,817 397,219
310,961 397,363

CREDITORS
Amounts falling due within one year 9 (19,900 ) (53,000 )

NET CURRENT ASSETS 291,061 344,363

TOTAL ASSETS LESS CURRENT LIABILITIES 306,586 361,958

NET ASSETS 306,586 361,958
FUNDS 10
Unrestricted funds 306,586 361,958
TOTAL FUNDS 306,586 361,958

The charitable company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2023.


The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2023 in accordance with Section 476 of the Companies Act 2006.


The trustees acknowledge their responsibilities for
(a)ensuring that the charitable company keeps accounting records that comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the charitable company as at the end of each financial year and of its surplus or deficit for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the charitable company.


BRITISH CARDIOVASCULAR INTERVENTION
SOCIETY (REGISTERED NUMBER: 07326046)

BALANCE SHEET - continued
30 SEPTEMBER 2023

These financial statements have been prepared in accordance with the provisions applicable to charitable companies subject to the small companies regime.


The financial statements were approved by the Board of Trustees and authorised for issue on 5 June 2024 and were signed on its behalf by:





D B McKenzie - Trustee

BRITISH CARDIOVASCULAR INTERVENTION
SOCIETY

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2023


1. STATUTORY INFORMATION

British Cardiovascular Intervention Society is a private company limited by guarantee and a charity, registered in England and Wales. The registered company and charity numbers, and the principal office address can be found under the reference and administrative details in the Report of the Trustees.

The presentation currency of the financial statements is the Pound Sterling (£)

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements of the charitable company, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The financial statements have also been prepared in accordance with the Charities Act 2011.

Financial reporting standard 102 - reduced disclosure exemptions
The charitable company has taken advantage of the following disclosure exemption in preparing these financial statements, as permitted by FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland':

the requirements of Section 7 Statement of Cash Flows.

Income
All income is accounted for on a receivable basis. There has been no offsetting of assets and liabilities, or income and expenses, unless required or permitted by FRS102 SORP or FRS102.

Expenditure
All expenditure is accounted for on an accruals basis.

The following principles have been applied in attributing costs to different headings:

i) Items of expenditure which involve more then one cost category have been apportioned on a basis consistent with the estimated use of the item within each category.

ii) No past expenditure incurred on activities falling directly within one cost category has been attributed to any other cost category.

Support costs have been allocated between governance and other support. Governance costs comprise all costs involving public accountability of the charity and its compliance with regulation and good practice.

Taxation
As a registered charity the Society is exempt from taxation on its income and gains where they are applied for charitable purposes.

The Society is not registered for VAT and accordingly expenditure is shown gross of irrecoverable VAT.

Fund accounting
Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees.

Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes.

Further explanation of the nature and purpose of each fund is included in the notes to the financial statements.

BRITISH CARDIOVASCULAR INTERVENTION
SOCIETY

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2023


2. ACCOUNTING POLICIES - continued

Debtors
Short term debtors are measured at transaction price, less any impairment.

Cash at bank
Cash at bank comprises current and deposit accounts.

Creditors
Short term creditors are measured at transaction price.

3. INVESTMENT INCOME
2023 2022
£    £   
Deposit account interest 1,723 35

4. NET INCOME/(EXPENDITURE)

Net income/(expenditure) is stated after charging/(crediting):

2023 2022
£    £   
Computer software amortisation 2,070 2,070

5. TRUSTEES' REMUNERATION AND BENEFITS

There were no trustees' remuneration or other benefits for the year ended 30 September 2023 nor for the year ended 30 September 2022.


Trustees' expenses

The following expenses were reimbursed to trustees:-

£266 in total was reimbursed for directly incurred expenditure to 1 trustee (2022:£104).

6. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES
Unrestricted
fund
£   
INCOME AND ENDOWMENTS FROM
Charitable activities
Cardiovascular care 240,354

Investment income 35
Total 240,389

EXPENDITURE ON
Charitable activities
Cardiovascular care 241,187

Other 2,070

BRITISH CARDIOVASCULAR INTERVENTION
SOCIETY

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2023


6. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued
Unrestricted
fund
£   
Total 243,257

NET INCOME/(EXPENDITURE) (2,868 )


RECONCILIATION OF FUNDS
Total funds brought forward 364,826

TOTAL FUNDS CARRIED FORWARD 361,958

7. INTANGIBLE FIXED ASSETS
Computer
software
£   
COST
At 1 October 2022 and 30 September 2023 20,700
AMORTISATION
At 1 October 2022 3,105
Charge for year 2,070
At 30 September 2023 5,175
NET BOOK VALUE
At 30 September 2023 15,525
At 30 September 2022 17,595

8. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 15,000 -
Other debtors 144 144
15,144 144


BRITISH CARDIOVASCULAR INTERVENTION
SOCIETY

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2023


9. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Other creditors 200 200
Accruals and deferred income 19,700 52,800
19,900 53,000

10. MOVEMENT IN FUNDS
Net
At movement At
1/10/22 in funds 30/9/23
£    £    £   
Unrestricted funds
General fund 361,958 (55,372 ) 306,586

TOTAL FUNDS 361,958 (55,372 ) 306,586

Net movement in funds, included in the above are as follows:

Incoming Resources Movement
resources expended in funds
£    £    £   
Unrestricted funds
General fund 331,478 (386,850 ) (55,372 )

TOTAL FUNDS 331,478 (386,850 ) (55,372 )


Comparatives for movement in funds

Net
At movement At
1/10/21 in funds 30/9/22
£    £    £   
Unrestricted funds
General fund 364,826 (2,868 ) 361,958

TOTAL FUNDS 364,826 (2,868 ) 361,958

BRITISH CARDIOVASCULAR INTERVENTION
SOCIETY

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2023


10. MOVEMENT IN FUNDS - continued

Comparative net movement in funds, included in the above are as follows:

Incoming Resources Movement
resources expended in funds
£    £    £   
Unrestricted funds
General fund 240,389 (243,257 ) (2,868 )

TOTAL FUNDS 240,389 (243,257 ) (2,868 )

A current year 12 months and prior year 12 months combined position is as follows:

Net
At movement At
1/10/21 in funds 30/9/23
£    £    £   
Unrestricted funds
General fund 364,826 (58,240 ) 306,586

TOTAL FUNDS 364,826 (58,240 ) 306,586

A current year 12 months and prior year 12 months combined net movement in funds, included in the above are as follows:

Incoming Resources Movement
resources expended in funds
£    £    £   
Unrestricted funds
General fund 571,867 (630,107 ) (58,240 )

TOTAL FUNDS 571,867 (630,107 ) (58,240 )

11. RELATED PARTY DISCLOSURES

There were no related party transactions for the year ended 30 September 2023.


BRITISH CARDIOVASCULAR INTERVENTION
SOCIETY

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2023


12. LIMITED BY GUARANTEE

The company is limited by guarantee without share capital. In the event of being wound up each member undertakes to contribute such amount as may be required (not exceeding £10) for the payment of the charity's debts and liabilities.